People · Operator
Named in public records as an officer, director or promoter · active 2015–2015 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Romark Global Pharma, LLC | — | Pharmaceuticals | Series A | $13.8M | $428.5M | 2015 |
Jean-Francois Rossignol, M.D., Ph.D. at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jean-Francois Rossignol, M.D., Ph.D. on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| W. Andrew Krusen, Jr. | 1 | 4 |
| Celine S. Rossignol | 1 | 2 |
| W. Seymour Holt | 1 | 2 |
| Marc S. Ayers | 1 | 2 |
| Brian S. Schnieders | 1 | 2 |
| Wayne S. Burks | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.